FGF7 and acute respiratory distress syndrome: The reasons may be as follows: the effect of giving KGF before lung injury is better than that after injury, local administration of intratracheal is better than systemic [42], heterogeneity for different reasons makes ARDS patients to have different effects on treatment, or exogenous KGF supplementation is not related to any other beneficial effects.